Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.1K
Skin Cancer01:30

Skin Cancer

5.5K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.5K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.2K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.2K
Cancer Vaccines01:30

Cancer Vaccines

764
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
764
Cancer Therapies02:49

Cancer Therapies

9.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Autologous, Vascularized and Immunocompetent Tissue Engineered Skin to Highlight Inter-Individual Variability to Better Understand the Human Wound Healing.

Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society·2026
Same author

Isolation and characterization of Aureobasidium pullulans from rose rhizosphere: A novel source for skin benefits.

International journal of cosmetic science·2025
Same author

Immune control of functional memory CD8 T cells in normal-appearing vitiligo skin.

Science advances·2025
Same author

DIS3 licenses B cells for plasma cell differentiation in humans.

Cellular & molecular immunology·2025
Same author

Guidelines for RNA Analysis by Reverse Transcription Quantitative Polymerase Chain Reaction.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Isolation of a Specific Transcript Using Biotinylated Antisense Probes.

Methods in molecular biology (Clifton, N.J.)·2025

Related Experiment Video

Updated: Dec 2, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.1K

Immunotherapies in cutaneous pathologies: an overview.

Audrey Baylet1, Marine Laclaverie2, Laëtitia Marchand2

  • 1Unité Mixte de Recherche CNRS 7276 - INSERM U1262 - Université de Limoges, CBRS, 2 rue du Dr Marcland, 87025 Limoges, France; Silab R&D Department, Brive, France.

Drug Discovery Today
|November 2, 2020
PubMed
Summary

This review covers current and developing biologic therapies for skin diseases like atopic dermatitis and psoriasis. It also explores novel immunotherapy delivery systems, including microneedle patches and nanoparticles.

More Related Videos

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.0K
High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research
09:12

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research

Published on: June 10, 2025

811

Related Experiment Videos

Last Updated: Dec 2, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.1K
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.0K
High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research
09:12

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research

Published on: June 10, 2025

811

Area of Science:

  • Dermatology and Immunology
  • Biotechnology and Drug Development

Background:

  • Skin serves as a critical barrier against pathogens.
  • Prevalence of skin conditions like atopic dermatitis (AD), psoriasis (PSO), and skin cancers is increasing.
  • Current treatments include antibody-based therapies, with ongoing research for targeted biologics.

Purpose of the Study:

  • To review existing biologic treatments for skin pathologies.
  • To discuss novel antibodies currently in development for dermatological conditions.
  • To explore innovative immunotherapy delivery technologies.

Main Methods:

  • Literature review of current biologics and antibodies in development for skin diseases.
  • Analysis of emerging immunotherapy delivery systems.
  • Synthesis of information on targeted therapies and novel formulations.

Main Results:

  • Established biologics are utilized for various skin diseases.
  • A pipeline of new antibodies targeting specific pathways is under investigation.
  • Advanced delivery systems such as microneedle patches, nanoparticles (NPs), liposomes, and gel formulations show promise for immunotherapy.

Conclusions:

  • Biologics represent a significant advancement in treating prevalent skin pathologies.
  • Ongoing research into targeted antibodies and novel delivery methods promises improved therapeutic outcomes.
  • Innovations in drug delivery are crucial for enhancing the efficacy and patient experience of immunotherapies for skin conditions.